Home  >  Products  >  MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) Blocking Peptide (the N terminal of MTRR)(100ug)
MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) Blocking Peptide (the N terminal of MTRR)(100ug)

MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) Blocking Peptide (the N terminal of MTRR)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MTRR Antibody(ARP57657_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57657
Size: 100ug
Weight: 80kDa
Gene: 4552
Format: Lyophilized powder
Target: Methionine is an essential amino acid required for protein synthesis and one-carbon metabolism. Its synthesis is catalyzed by the enzyme methionine synthase. Methionine synthase eventually becomes inactive due to the oxidation of its cob(I)alamin cofactor. The protein encoded by this gene regenerates a functional methionine synthase via reductive methylation. It is a member of the ferredoxin-NADP(+) reductase (FNR) family of electron transferases. Patients of the cbl-E complementation group of disorders of folate/cobalamin metabolism are defective in reductive activation of methionine synthase. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms.
Alternative names: MGC129643; MSR
See Full Product Listings >